Not All Children with Cystic Fibrosis Have Abnormal Esophageal Neutralization during Chemical Clearance of Acid Reflux

다국어 초록 (Multilingual Abstract)

Purpose: Acid neutralization during chemical clearance is significantly prolonged in children with cystic fibrosis, com-pared to symptomatic children without cystic fibrosis. The absence of available reference values impeded identi-fication of abnormal findings within individual patients with and without cystic fibrosis. The present study aimed to test the hypothesis that significantly more children with cystic fibrosis have acid neutralization durations during chem-ical clearance that fall outside the physiological range. Methods: Published reference value for acid neutralization duration during chemical clearance (determined using combined impedance/pH monitoring) was used to assess esophageal acid neutralization efficiency during chemical clearance in 16 children with cystic fibrosis (3 to ＜18 years) and 16 age-matched children without cystic fibrosis.Results: Duration of acid neutralization during chemical clearance exceeded the upper end of the physiological range in 9 of 16 (56.3%) children with and in 3 of 16 (18.8%) children without cystic fibrosis (p=0.0412). The likelihood ratio for duration indicated that children with cystic fibrosis are 2.1-times more likely to have abnormal acid neutraliza-tion during chemical clearance, and children with abnormal acid neutralization during chemical clearance are 1.5-times more likely to have cystic fibrosis. Conclusion: Significantly more (but not all) children with cystic fibrosis have abnormally prolonged esophageal clear-ance of acid. Children with cystic fibrosis are more likely to have abnormal acid neutralization during chemical clearance. Additional studies involving larger sample sizes are needed to address the importance of genotype, esophageal motility, composition and volume of saliva, and gastric acidity on acid neutralization efficiency in cystic fibrosis children.

참고문헌 (Reference)

1 Tuttle SG, "The physiology of heartburn" 55 : 292-300, 1961

2 Vaezi MF, "Role of acid and duodenogastric reflux in esophageal injury: a review of animal and human studies" 108 : 1897-1907, 1995

3 Simrén M, "Relevance of ineffective oesophageal motility during oesophageal acid clearance" 52 : 784-790, 2003

4 Orlando RC, "Overview of the mechanisms of gastroesophageal reflux" 111 (111): 174S-177S, 2001

5 Boyd DD, "Neurohumoral control of esophageal epithelial electrolyte transport" 239 : G5-G11, 1980

6 Pauwels A, "Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis" 107 : 1346-1353, 2012

7 Dodds WJ, "Mechanisms of gastroesophageal reflux in patients with reflux esophagitis" 307 : 1547-1552, 1982

8 Abdulnour-Nakhoul S, "Lumen-to-surface pH gradients in opossum and rabbit esophagi: role of submucosal glands" 278 : G113-G120, 2000

9 Abdulnour-Nakhoul S, "Ion transport mechanisms linked to bicarbonate secretion in the esophageal submucosal glands" 301 : R83-R96, 2011

10 Meyers RL, "In vivo bicarbonate secretion by human esophagus" 103 : 1174-1178, 1992

11 Hamilton BH, "In vivo alkaline secretion by mammalian esophagus" 97 : 640-648, 1989

12 Vanscoy LL, "Heritability of lung disease severity in cystic fibrosis" 175 : 1036-1043, 2007

13 Pauwels A, "Gastric emptying and different types of reflux in adult patients with cystic fibrosis" 34 : 799-807, 2011

14 Navarro J, "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF" 18 : 298-305, 2001

15 Orlando RC, "Esophageal mucosal defense mechanisms. Part 1 Oral cavity, pharynx, and esophagus" 2006

16 Frazzoni M, "Esophageal chemical clearance is impaired in gastro-esophageal reflux disease--a 24-h impedance-pH monitoring assessment" 25 : 399-406, 2013

17 Martinucci I, "Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn" 26 : 546-555, 2014

18 Sivalingam M, "Effects of esophageal acidification on troublesome symptoms: an approach to characterize true acid GERD in dysphagic neonates" 32 : 509-519, 2017

19 Helm JF, "Effect of esophageal emptying and saliva on clearance of acid from the esophagus" 310 : 284-288, 1984

20 Richter J, "Do we know the cause of reflux disease?" 11 (11): S3-S9, 1999

21 Woodley FW, "Diurnal variation in the chemical clearance of acid gastroesophageal reflux in infants" 5 : 37-43, 2007

22 Maclean JE, "Cystic fibrosis newborn screening does not delay the identification of cystic fibrosis in children with negative results" 10 : 333-337, 2011

23 Woodley FW, "Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis" 59 : 623-630, 2014

24 Woodley FW, "Chemical clearance in infants and children with acid reflux in the physiologic range" 60 : 783-786, 2015

25 Mekus F, "Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics" 3 : 277-293, 2000

26 Pauwels A, "Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis" 141 : 1568-1574, 2012

27 Frazzoni M, "Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease" 14 : 40-46, 2016